Literature DB >> 14458280

Urinary excretion of 3-methoxy-4-hydroxymandelic acid in children with neuroblastoma.

S B KONTRAS.   

Abstract

Entities:  

Keywords:  MANDELIC ACID/related compounds; NEUROBLASTOMA/in infancy and childhood

Mesh：

Substances：

Year:  1962        PMID： 14458280     DOI： 10.1002/1097-0142(196209/10)15:5<978::aid-cncr2820150514>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  CONGENITAL DOPAMINE-SECRETING NEUROBLASTOMA WITH CLINICAL AND BIOCHEMICAL REMISSION.

Authors:  E M BRETT; T E OPPE; C R RUTHVEN; M SANDLER
Journal:  Arch Dis Child       Date:  1964-08       Impact factor: 3.791

2.  Intramedullary secretory gangliocytoma.

Authors:  B Azzarelli; T G Luerssen; T M Wolfe
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Circadian rhythms. Before and after removal of both eyes for bilateral retinoblastoma.

Authors:  H Levine; D Taylor; F Halberg
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1973-11-06

Review 4.  Catecholamine-secreting tumours.

Authors:  M Sandler
Journal:  Proc R Soc Med       Date:  1967-08

5.  Chronic diarrhea in an adult with hypokalemic nephropathy and osteomalacia due to a functioning ganglioneuroblastoma.

Authors:  D G Cameron; H A Warner; A J Szabo
Journal:  Trans Am Clin Climatol Assoc       Date:  1967

6.  Watery diarrhoea with a vasoactive intestinal peptide-producing ganglioneuroblastoma.

Authors:  Y Iida; O Nose; H Kai; A Okada; T Mori; P K Lee; K Kakudo; N Yanaihara
Journal:  Arch Dis Child       Date:  1980-12       Impact factor: 3.791

7.  Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma.

Authors:  Giuliana Cangemi; Giorgio Reggiardo; Sebastiano Barco; Laura Barbagallo; Massimo Conte; Paolo D'Angelo; Maurizio Bianchi; Claudio Favre; Barbara Galleni; Giovanni Melioli; Riccardo Haupt; Alberto Garaventa; Maria V Corrias
Journal:  Onco Targets Ther       Date:  2012-11-30       Impact factor: 4.147
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.